Enhancement of Cellular Immunity in Melanoma Patients Immunized with a Peptide from MART-1/Melan A

PURPOSE: In this study, we tested the effectiveness of a melanoma-associated antigen–derived peptide, MART-1(27–35), in eliciting cellular immune responses in vivo in the context of a phase I active immunization protocol. This peptide (AAGIGILTV) corresponds to residues 27–35 from the nonmutated mel...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cormier, Janice N., Salgaller, Michael L., Prevette, Tracy, Barracchini, Kathleen C., Rivoltini, Licia, Restifo, Nicholas P., Rosenberg, Steven A., Marincola, Francesco M.
Format: Artigo
Langue:Inglês
Publié: 1997
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597550/
https://ncbi.nlm.nih.gov/pubmed/9072306
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires